Protons, Photons, & everything in between. Join us on July 15th as we breakdown NRG-GI003 comparing protons & photons for hepatocellular carcinoma with study PI, Dr. Ted Hong. Listen to older episodes and find where to follow at nrgoncology.org/Podcast #LiverTwitter #LiverX #HCC

Evaluating the positive predictive value of code-based… : Hepatology To assess LLMs’ potential for cirrhosis cohort identification, we compared code-based versus LLM-based classification with chart review as a “gold standard.” Approach and Results: We extracted and conducted a limited chart review of 3788 discharge summaries of cirrhosis admissions. We engineered zero-shot prompts using a Generative Pre-trained Transformer 4 to determine whether cirrhosis and its complications were active hospitalization problems. We calculated positive predictive values (PPVs) of LLM-based classification versus limited chart review and PPVs of code-based versus LLM-based classification as a “silver standard” in all 3788 summaries. Compared to gold standard chart review, code-based classification achieved PPVs of 82.2% for identifying cirrhosis, 41.7% for HE, 72.8% for ascites, 59.8% for gastrointestinal bleeding, and 48.8% for spontaneous bacterial peritonitis. Compared to the chart review, Generative Pre-trained Transformer 4 achieved 87.8%–98.8% accuracies for identi Read the full article here

Evaluating the positive predictive value of code-based… : Hepatology To assess LLMs’ potential for cirrhosis cohort identification, we compared code-based versus LLM-based classification with c...

#General #Medicine #News #LiverX

Origin | Interest | Match

#LiverX #AustrianGI/Liver Society
Hepatologischer Frühling #Graz

🐘 #MASLD #MASH #Cirrhosis broad entity of pts with differing disease drivers

🎯 #Combined non-invasive tests #NITs for #Fibrosis & #PortalHypertension will enrich #atrisk population in #clinicaltrials

@natureportfolio.nature.com

Definitely finding it hard to post on 3 different SoMe platforms for #TLM24

More posts on #LiverX and LinkedIn if interested…

Moving forward though a lot more coming to #BluerSkies

Calling all #LiverTwitter #LiverX #GITwitter #GIX #MedTwitter #MedX friends! 👇

I will try to cover viral hepatitis during AASLD The Liver Meeting 2024 #TLM24 next week (virtual attendance)

Anyone from #LiverTwitter #LiverX here so far #Medsky ?

#IDsky